Viz Research

LVO Stroke Management Practices Are Changing. Are you Up to Speed?

Stroke management practices are changing as a result of seminal trials including SWIFT PRIME, REVASCAT, EXTEND-IA, MR CLEAN, ESCAPE, DAWN and DEFUSE 3. The evidence for mechanical thrombectomy is clear. It works. Timely diagnosis of LVO strokes and early access to definitive treatments are more critical than ever.

Slider
Slider

Viz LVO detecting proximal M2 occlusions

November 15, 2018

Viz LVO detected ICA-T, M1 and proximal M2 occlusions with a sensitivity of 86% and a specificity of 87% in 495 CTA images and…

Slider

Viz ICH shows accurate detection and measurement of bleeds

November 17, 2018

Viz ICH automatically detected intracerebral hemorrhage with a sensitivity of 93% and a specificity of 95% in 191 NCCT images…

Slider

Viz HDVS presented at the podium

November 17, 2018

Viz LVO detected anterior LVOs, extending from ICA-T to MCA-M1, with a sensitivity of 90% and a specificity of 86% in 875 CTA images.

Slider

Viz LVO shows remarkable performance at ESOC 2018

May 17, 2018

Viz LVO detected anterior LVOs, extending from ICA-T to MCA-M1, with a sensitivity of 90% and a specificity of 86% in 875 CTA images and with a maximal runtime of 5 minutes.

Research and Society Collaborations

Viz.ai and NICO Corp. Announce Collaboration to Speed Patient Recruitment in the ENRICH Study

Viz.ai, a leading applied artificial intelligence company in healthcare, and NICO Corporation, a leader in modern minimally invasive interventional technologies for neurosurgery, have announced a collaboration to incorporate a new innovative...

Viz.ai Designated as AHA/ASA GWTG® Compatible Vendor

Viz.ai, Inc., an applied artificial intelligence company, has been designated as a compatible vendor for the American Heart Association/American Stroke Association Get With The Guidelines registry, the premier...

previous arrow
next arrow
Slider

Conference Participation

ics_2018_logo
esoc_logo
svin_logo
snis_logo

Research Inquiries?